Bb5a31f81ClaimMETR found that the pace of capability improvement for Anthropic AI models roughly doubled over the course of a yearAgreeDisagree
Bb5a31f81ClaimAnthropic defines its recursive self-improvement danger threshold as achieving as much AI capability progress in one year as occurred between 2018 and 2024AgreeDisagree
Bb5a31f81ClaimIn technology and pharmaceuticals, the term "valley of death" describes the gap between developing laboratory prototypes and achieving commercial sustainability or deploymentAgreeDisagree
Bb5a31f81ClaimIn the defense sector, the term "valley of death" refers to the gulf between developing prototypes in the laboratory and deploying them to military personnel on the battlefieldAgreeDisagree
Bb5a31f81ClaimMaintaining a decisive strategic advantage achieved via a rapid takeoff is vulnerable to erosion over time through model theft, model distillation, and diffusionAgreeDisagree
Bb5a31f81ClaimAnthropic conducts early access evaluation testing with external API customers including CognitionAgreeDisagree
Bb5a31f81ClaimAnthropic conducts internal testing referred to as ant-fooding on candidate model variants prior to cutting versions for external API customersAgreeDisagree
Bb5a31f81ClaimBiotechnology researchers in Boston have cultured human stem cells into cardiac organoids to generate laboratory-grown heart tissue for direct myocardial injectionAgreeDisagree
Bb5a31f81ClaimLeash Bio utilizes DNA-encoded libraries to screen millions of chemical compounds against thousands of proteinsAgreeDisagree
Bb5a31f81ClaimSince its founding, Leash Bio has screened approximately 1,000 proteins against chemical librariesAgreeDisagree
Bb5a31f81ClaimLeonardo de Moura developed the Z3 automated theorem prover at Microsoft Research to automatically check software pathways for bugsAgreeDisagree
Bb5a31f81ClaimLeash Bio produces two pre-measured protein-screening environments per dayAgreeDisagree
Bb5a31f81ClaimLeash Bio established an operational goal to scale production to 20 pre-measured protein-screening environments per dayAgreeDisagree
Bb5a31f81ClaimResearch presented at the IEEE Electronic Components and Technology Conference demonstrated hybrid-bonded devices functioning at a 0.45-micrometer pitchAgreeDisagree
Bb5a31f81ClaimFinFET was demonstrated in a laboratory in 1989 and reached volume production at Intel in 2011AgreeDisagree
Bb5a31f81ClaimIntel researchers prototype simplified CFET vehicles consisting of one NMOS wire and one PMOS wire to evaluate device stackingAgreeDisagree
Bb5a31f81ClaimSpencer McIntyre transitioned into exploit research and development after working in cybersecurity consultingAgreeDisagree
Bb5a31f81ClaimPreclinical mouse studies and molecule discovery typically cost 50 million dollars and take two to three years of drug developmentAgreeDisagree
Bb5a31f81ClaimDeveloping a commercial drug typically takes 15 years and costs approximately 1.5 billion dollarsAgreeDisagree
Bb5a31f81ClaimClinical trials typically account for more than 1.4 billion dollars and 12 years of drug development costsAgreeDisagree